Cue Biopharma, Inc.

SecurityCUE / Cue Biopharma, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership875 shares
Latest Disclosed Value $ 201
Simplex Trading, Llc ownership in CUE / Cue Biopharma, Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 875 shares of Cue Biopharma, Inc. (US:CUE) valued at $201 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 2,557 shares of Cue Biopharma, Inc.. The current value of the position is $26,092 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (CUE) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CUE / Cue Biopharma, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CUE BIOPHARMA COM 22978P106 875 -1,682 -65.78 0 0.0000
2026-02-11 2025-12-31 13F CUE BIOPHARMA COM 22978P106 2,557 -2,275 -47.08 1 0.0000
2025-11-12 2025-09-30 13F CUE BIOPHARMA COM 22978P106 4,832 4,832 0 0.0000
2025-08-05 2025-06-30 13F CUE BIOPHARMA COM 22978P106 0 -2,395 -100.00 0 0.0000
2025-05-12 2025-03-31 13F CUE BIOPHARMA COM 22978P106 2,395 -4,513 -65.33 0 0.0000
2025-02-11 2024-12-31 13F CUE BIOPHARMA COM 22978P106 6,908 2,852 70.32 0 0.0000
2024-11-08 2024-09-30 13F CUE BIOPHARMA COM 22978P106 4,056 4,056 0 0.0000
2024-07-25 2024-06-30 13F CUE BIOPHARMA COM 22978P106 0 -9,531 -100.00 0 0.0000
2024-04-25 2024-03-31 13F CUE BIOPHARMA COM 22978P106 9,531 9,531 0 0.0000
2024-02-02 2023-12-31 13F CUE BIOPHARMA COM 22978P106 0 -22,317 -100.00 0 0.0000
2023-11-01 2023-09-30 13F CUE BIOPHARMA COM 22978P106 22,317 22,317 0 0.0000
2023-08-04 2023-06-30 13F CUE BIOPHARMA COM 22978P106 0 -11,586 -100.00 0 0.0000
2023-04-27 2023-03-31 13F CUE BIOPHARMA COM 22978P106 11,586 11,586 0 0.0000
2023-02-02 2022-12-31 13F CUE BIOPHARMA COM 22978P106 0 -16,400 -100.00 0 -100.00
2022-11-04 2022-09-30 13F CUE BIOPHARMA COM 22978P106 16,400 -1,420 -7.97 36 -18.18 0.0000
2022-08-03 2022-06-30 13F CUE BIOPHARMA COM 22978P106 17,820 15,003 532.59 44 238.46 0.0000
2022-05-02 2022-03-31 13F CUE BIOPHARMA COM 22978P106 2,817 -8,718 -75.58 13 -90.00 0.0000
2022-02-23 2021-12-31 13F/A-1 CUE BIOPHARMA COM 22978P106 11,535 4,124 55.65 130 44.44 0.0001
2022-02-04 2021-12-31 13F CUE BIOPHARMA COM 22978P106 7,411 0 90 0.0000
2021-10-28 2021-09-30 13F CUE BIOPHARMA COM 22978P106 7,411 600 8.81 90 13.92 0.0001
2021-08-12 2021-06-30 13F CUE BIOPHARMA COM 22978P106 6,811 -3,110 -31.35 79 -34.71 0.0001
2021-04-26 2021-03-31 13F CUE BIOPHARMA COM 22978P106 9,921 9,921 45.66 121 53.16 0.0002
2020-10-14 2020-09-30 13F CUE BIOPHARMA COM 22978P106 0 -446 -100.00 0 -100.00
2020-07-13 2020-06-30 13F CUE BIOPHARMA COM 22978P106 446 -538 -54.67 10 -23.08 0.0000
2020-04-29 2020-03-31 13F CUE BIOPHARMA COM 22978P106 984 984 13 0.0000
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F CUE BIOPHARMA PUT Put 2,100 950.00 0 n/a n/a n/a
2026-02-11 2025-12-31 13F CUE BIOPHARMA PUT Put 200 100.00 0 n/a n/a n/a
2025-11-12 2025-09-30 13F CUE BIOPHARMA PUT Put 100 0.00 0 n/a n/a n/a
2025-08-05 2025-06-30 13F CUE BIOPHARMA PUT Put 100 -90.91 0 n/a n/a n/a
2025-05-12 2025-03-31 13F CUE BIOPHARMA PUT Put 1,100 0 n/a n/a n/a
2025-02-11 2024-12-31 13F CUE BIOPHARMA PUT Put 0 -100.00 0 n/a n/a n/a
2024-11-08 2024-09-30 13F CUE BIOPHARMA PUT Put 2,000 0.00 0 n/a n/a n/a
2024-07-25 2024-06-30 13F CUE BIOPHARMA PUT Put 2,000 -68.25 0 n/a n/a n/a
2024-04-25 2024-03-31 13F CUE BIOPHARMA PUT Put 6,300 350.00 0 n/a n/a n/a
2024-02-02 2023-12-31 13F CUE BIOPHARMA PUT Put 1,400 366.67 0 n/a n/a n/a
2023-11-01 2023-09-30 13F CUE BIOPHARMA PUT Put 300 -97.52 0 n/a n/a n/a
2023-08-04 2023-06-30 13F CUE BIOPHARMA PUT Put 12,100 -17.12 0 n/a n/a n/a
2023-04-27 2023-03-31 13F CUE BIOPHARMA PUT Put 14,600 17.74 0 n/a n/a n/a
2023-02-02 2022-12-31 13F CUE BIOPHARMA PUT Put 12,400 21.57 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F CUE BIOPHARMA PUT Put 10,200 12.09 22 0.00 n/a n/a n/a
2022-08-03 2022-06-30 13F CUE BIOPHARMA PUT Put 9,100 -54.04 22 -77.08 n/a n/a n/a
2022-05-02 2022-03-31 13F CUE BIOPHARMA PUT Put 19,800 1,700.00 96 700.00 n/a n/a n/a
2022-02-23 2021-12-31 13F/A CUE BIOPHARMA PUT Put 1,100 -83.58 12 -85.37 n/a n/a n/a
2022-02-04 2021-12-31 13F CUE BIOPHARMA PUT Put 6,700 82 n/a n/a n/a
2021-10-28 2021-09-30 13F CUE BIOPHARMA PUT Put 6,700 0.00 82 5.13 n/a n/a n/a
2021-08-12 2021-06-30 13F CUE BIOPHARMA PUT Put 6,700 13,300.00 78 30.00 n/a n/a n/a
2021-04-26 2021-03-31 13F CUE BIOPHARMA PUT Put 50 -99.25 60 -23.08 n/a n/a n/a
2020-10-14 2020-09-30 13F CUE BIOPHARMA PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F CUE BIOPHARMA PUT Put 1 -98.77 2 -98.25 n/a n/a n/a
2020-04-29 2020-03-31 13F CUE BIOPHARMA PUT Put 81 114 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.